GB0520365D0 - Crystal structure of CD44 and its use - Google Patents
Crystal structure of CD44 and its useInfo
- Publication number
- GB0520365D0 GB0520365D0 GBGB0520365.8A GB0520365A GB0520365D0 GB 0520365 D0 GB0520365 D0 GB 0520365D0 GB 0520365 A GB0520365 A GB 0520365A GB 0520365 D0 GB0520365 D0 GB 0520365D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- crystal structure
- crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70585—CD44
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0520365.8A GB0520365D0 (en) | 2005-10-06 | 2005-10-06 | Crystal structure of CD44 and its use |
PCT/GB2006/003734 WO2007039761A2 (en) | 2005-10-06 | 2006-10-06 | Crystal structure of cd44 and its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0520365.8A GB0520365D0 (en) | 2005-10-06 | 2005-10-06 | Crystal structure of CD44 and its use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0520365D0 true GB0520365D0 (en) | 2005-11-16 |
Family
ID=35429941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0520365.8A Ceased GB0520365D0 (en) | 2005-10-06 | 2005-10-06 | Crystal structure of CD44 and its use |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0520365D0 (en) |
WO (1) | WO2007039761A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2403518A4 (en) * | 2009-03-06 | 2013-01-23 | Angstrom Pharmaceuticals Inc | Compositions and methods for modulation of cell migration |
US8697629B2 (en) | 2010-03-05 | 2014-04-15 | Angstrom Pharmaceuticals, Inc. | Modulation of intracellular signaling |
EP4153192A1 (en) | 2020-05-19 | 2023-03-29 | Institut Curie | Methods for the diagnosis and treatment of cytokine release syndrome |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003228872A1 (en) * | 2002-05-10 | 2003-11-11 | Incyte Corporation | Cell adhesion and extracellular matrix proteins |
-
2005
- 2005-10-06 GB GBGB0520365.8A patent/GB0520365D0/en not_active Ceased
-
2006
- 2006-10-06 WO PCT/GB2006/003734 patent/WO2007039761A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007039761A2 (en) | 2007-04-12 |
WO2007039761A3 (en) | 2007-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1913112A4 (en) | Proppant and methods of use | |
IL188078A0 (en) | Nano-ionic liquids and methods of use | |
ZA200802501B (en) | Indenoisoquinolinone analogs and methods of use thereof | |
EP1951680A4 (en) | Novel 2-aminopyrimidinone derivatives and their use | |
EP2021555A4 (en) | Structural element and methods of use thereof | |
GB2440843B (en) | Liquid sealant and methods of use | |
EP1951682A4 (en) | Novel 2-aminopyrimidinone or 2-aminopyridinone derivatives and their use | |
IL192046A0 (en) | Vip fragments and methods of use | |
IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
EP1878753A4 (en) | Acerola fruit-derived pectin and use thereof | |
PT2380573E (en) | Eslicarbazepine acetate and methods of use | |
IL190039A0 (en) | Supercritical flat panel collector and methods of use | |
IL189252A0 (en) | Dihydroxyanthraquinones and their use | |
EP1933805A4 (en) | Anti-inflammatory compositions and methods of use | |
HK1161122A1 (en) | Use of 24-norudca 24-norudca | |
EP1931385A4 (en) | (s)-6-methyloxaalkyl exemestane compounds and related methods of use | |
EP1893993A4 (en) | Crystal of a cytochrome-ligand complex and methods of use | |
GB0520365D0 (en) | Crystal structure of CD44 and its use | |
EP1931370A4 (en) | Use of des-aspartate-angiotensin i | |
PL1902047T3 (en) | Carboxamide compound and use of the same | |
EP1978999A4 (en) | Isolated mcpip and methods of use | |
EP1709445A4 (en) | Itpks as modifiers of the igfr pathway and methods of use | |
GB0608797D0 (en) | Novel agents and the use thereof | |
AU2007297869A8 (en) | Crystal structure of CRIg and C3b: CRIg complex | |
GB0715284D0 (en) | Crystal structure of ampk and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |